Rasbelon 1.5 mg Injection
91,80$
63,47$
Rasbelon 1.5 mg Injection is an effective treatment designed to manage elevated uric acid levels in the bloodstream, a condition medically termed hyperuricemia. This medication is especially beneficial for patients receiving chemotherapy for various cancers, including leukemia, lymphoma, and solid tumors, as well as those experiencing tumor lysis syndrome (TLS), a serious complication associated with cancer therapies. Rasbelon functions by transforming uric acid into allantoin, a more soluble substance that the kidneys can easily eliminate, thus reducing the risk of associated complications. It is important for patients to be aware of potential side effects, and healthcare professionals should monitor renal function during treatment to ensure safety. Given its critical role in managing uric acid levels, Rasbelon is a vital option for those undergoing intensive cancer treatments. As with any medication, adherence to prescribed dosages and medical guidance is essential for optimal results. Always consult your healthcare provider for personalized advice and to discuss any concerns regarding Rasbelon and its use in your treatment plan.
Quantité
Active Pharmaceutical Ingredient
Uses
• Rasbelon 1 5 mg injection is primarily used to manage hyperuricemia, particularly in patients undergoing chemotherapy. This condition often arises as a complication of tumor lysis syndrome (TLS), where rapid cell breakdown leads to increased uric acid levels. By effectively lowering uric acid, Rasbelon 1 5 mg injection helps mitigate the risk of related complications. This is especially important in patients with high tumor burdens.
• In patients receiving chemotherapy, the risk of tumor lysis syndrome can be significant, leading to severe metabolic disturbances. Rasbelon 1 5 mg injection plays a crucial role in preventing these disturbances by managing uric acid levels. It acts promptly to dissolve excess uric acid, thereby protecting kidney function and overall health. This makes it a vital component of supportive care during cancer treatment.
• Rasbelon 1 5 mg injection is also beneficial for patients who exhibit elevated uric acid levels due to rapid cell turnover. This can occur not just in cancer patients but in other conditions requiring intensive treatment. By administering Rasbelon 1 5 mg injection, healthcare providers can help reduce the likelihood of acute gout attacks and other complications associated with high uric acid. This proactive approach ensures better patient outcomes during therapy.
• Additionally, Rasbelon 1 5 mg injection is indicated for use in specific clinical settings where uric acid control is critical. This includes patients with hematologic malignancies who are at higher risk for TLS. The timely use of Rasbelon 1 5 mg injection can help maintain metabolic balance during treatment. Consequently, it supports clinicians in providing comprehensive care to their patients.
Benefits
Rasbelon 1.5 mg Injection is helpful for people who have to deal with too much uric acid, especially if they have certain types of cancer or are having chemotherapy. It works by lowering uric acid levels, which can relieve things like joint pain and swelling caused by too much uric acid in the body. It also helps to prevent problems such as kidney stones or damage caused by the formation of uric acid crystals. By tackling these problems, rasburicase helps people feel better overall and makes it easier for them to recover during treatment.
Side Effects
Like all medicines, Rasbelon 1.5 mg Injection may cause side effects that do not require medical attention and will disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're concerned about them.
Most Common Side Effects
• Anxiety
• Fever
• Vomiting
• Joint pain
• Mouth sores/ulcers
• Swollen Limbs
• Injection site pain
Common Side Effects
• Yellowing Eyes
• Dark urine
• Bluish or Grey-coloured skin
• Injection site Pain
• Nausea
• Constipation
• Diarrhea
• Abdominal pain
• Throat pain
• Headche
How To Use
Using Rasbelon 1.5 mg Injection typically involves getting it through an intravenous (IV) infusion. A healthcare professional will administer it directly into your vein, usually in a hospital or clinic setting. The dosage and frequency of rasburicase injections will depend on your specific medical condition and your doctor's recommendations. It's essential to follow your healthcare provider's instructions carefully and attend all scheduled appointments for Rasbelon 1.5 Injection treatment. They'll monitor your response to the medication and adjust your treatment plan as needed to ensure the best results and minimize any potential side effects.
Safety Advice
• Alcohol: Consuming alcohol may affect the effectiveness of Rasbelon 1.5 Injection. If you are taking rasburicase, it is recommended to stop consuming alcohol to ensure the medication works properly.
• Kidney: Rasbelon 1.5 mg Injection is safe for patients with kidney disease, and no dose adjustment is necessary. While taking Rasbelon 1.5 Injection, regular monitoring of blood tests may be recommended to ensure optimal health and effective treatment.
• Breastfeeding: It is unknown if Rasbelon 1.5 mg Injection passes into breast milk or how it might affect your baby. Please consult your doctor before breastfeeding if you are receiving Rasbelon 1.5 mg treatment.
• Liver: It is unknown whether Rasbelon 1.5 mg Injection can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with Rasbelon 1.5 Injection.
• Pregnancy: It is unsafe to use Rasbelon 1.5 mg Injection during pregnancy. If you are pregnant or planning to become pregnant during the treatment, consult your doctor before taking Rasbelon 1.5 Injection.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking Rasbelon 1.5 mg because it contains a small amount of alcohol, which may cause dizziness and impair your concentration.